Aduhelm, One Year Later: US FDA’s Credibility, Accelerated Approval Pathway Feel The Bite From Alzheimer’s Drug Approval

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.